Abstract

We investigated the effect of Lipofundin MCT/LCT and Intralipid on acetylcholine-induced nitric oxide- (NO-) mediated relaxation in rat aorta to determine which lipid emulsion (LE) is more potent in terms of inhibition of NO-induced relaxation. Dose-response curves of responses induced by acetylcholine, the calcium ionophore A23187, and sodium nitroprusside were generated using isolated rat aorta with or without LE. The effect of Lipofundin MCT/LCT on acetylcholine-induced endothelial nitric oxide synthase (eNOS) phosphorylation in human umbilical vein endothelial cells (HUVECs) was investigated using western blotting. Lipofundin MCT/LCT (0.1 and 0.2%) attenuated acetylcholine-induced relaxation in endothelium-intact aorta with or without tiron, whereas 0.2% Intralipid only inhibited relaxation. Lipofundin MCT/LCT inhibited relaxation induced by the calcium ionophore A23187 and sodium nitroprusside in endothelium-intact aorta, but Lipofundin MCT/LCT had no effect on sodium nitroprusside-induced relaxation in the endothelium-denuded aorta. Combined pretreatment with l-arginine plus Lipofundin MCT/LCT increased acetylcholine-induced maximal relaxation in endothelium-intact aorta compared with Lipofundin MCT/LCT alone. l-Arginine attenuated Lipofundin MCT/LCT-mediated inhibition of acetylcholine-induced eNOS phosphorylation in HUVECs. Taken together, Lipofundin MCT/LCT attenuated acetylcholine-induced NO-mediated relaxation via an inhibitory effect on the endothelium including eNOS, which is proximal to activation of guanylyl cyclase.

Highlights

  • Intravenous lipid emulsion (LE) has been used for parenteral nutrition when the oral and enteral route is not available

  • This study suggests that the magnitude of LE-mediated inhibition of acetylcholine-induced nitric oxide- (NO-)mediated relaxation in the isolated rat aorta appears to be dependent on the fatty acid components of LE

  • Considering previous reports, in our current study, Lipofundin MCT/LCT-mediated enhanced inhibition of acetylcholine-induced nitric oxide (NO)-mediated relaxation may be associated with differences in fatty acid components that are contained in LE such as increased medium-chain fatty acids and decreased long-chain fatty acids [8, 10, 11, 17, 20, 27, 28]

Read more

Summary

Introduction

Intravenous lipid emulsion (LE) has been used for parenteral nutrition when the oral and enteral route is not available. LEs such as either Intralipid 20% containing 100% long-chain triglycerides or Lipofundin MCT/LCT 20% containing 50% long-chain triglycerides and 50% medium-chain triglycerides are effective for treatment of cardiovascular collapse induced by a toxic dose of local anesthetics including bupivacaine, levobupivacaine, ropivacaine, mepivacaine, and lidocaine [1,2,3,4,5,6,7]. LE containing only longchain triglycerides has no effect on blood pressure, whereas LE containing both medium-chain triglycerides and longchain triglycerides causes an increase in blood pressure [12]. Intralipid increases blood pressure and inhibits acetylcholine-induced NO-mediated vasorelaxation [13,14,15,16,17]. Intravenous administration of LE produces increased left ventricular systolic pressure, and pretreatment

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call